Does A Therapy for Reflex Vasovagal Syncope Really Exist?

被引:0
作者
Simone Romano
Lorella Branz
Luigi Fondrieschi
Pietro Minuz
机构
[1] University of Verona,Syncope Unit, Section of General Medicine and Hypertension, Department of Medicine
[2] Policlinico GB Rossi,undefined
来源
High Blood Pressure & Cardiovascular Prevention | 2019年 / 26卷
关键词
Reflex syncope; Vasovagal syncope; Treatment; Pacemaker; American and European guidelines; Blood pressure;
D O I
暂无
中图分类号
学科分类号
摘要
Syncope is a temporary loss of consciousness due to transient global cerebral hypoperfusion. Reflex syncope is the most frequent, representing 21% of all types of syncopal events, and includes: (a) the vasovagal syncope (classical type); (b) the situational syncope; (c) the carotid sinus syncope and (d) non-classical forms. An accurate anamnesis and physical examination are fundamental for the diagnosis. Although limited evidence is available regarding the efficacy of some treatments, a number of these can be successfully used in the clinical practice. It is, however, important to personalize the therapeutic approach in order to achieve an efficient reduction or suppression of syncopal episodes. Patients should be reassured about the benignity of these events and the possibility of reducing their frequency over time. They should be also educated on how to recognize and abort incoming syncopal episodes. Patients may be advised to increase their introit in water and salt, as well as to reduce vasoactive medications, if no contraindications exist. Orthostatic training may be beneficial but only in very motivated young patients capable of strictly adhering to the exercise plan. So far, any proposed pharmacological treatment has demonstrated very limited efficacy and, therefore, it should be tried in case of failure of non-pharmacological approaches. Pacemaker implantation is clearly indicated in patients with documented cardioinhibitory syncope in the absence of a vasodepressor component, which can compromise their quality of life. Despite the American and European guidelines for the treatment of syncope are similar, still some differences can be denoted. Aim of this study is to evaluate the management of patients with recurrent syncopal episodes focusing on pharmacological and non-pharmacological approaches.
引用
收藏
页码:273 / 281
页数:8
相关论文
共 501 条
  • [1] Brignole M(2018)2018 ESC Guidelines for the diagnosis and management of syncope Eur Heart J 39 1883-1948
  • [2] Moya A(2014)Syncope: epidemiology, etiology, and prognosis Front Physiol 5 471-885
  • [3] de Lange FJ(2002)Incidence and prognosis of syncope N Engl J Med 347 878-2906
  • [4] Deharo JC(2000)The elusive pathophysiology of neurally mediated syncope Circulation 102 2898-2513
  • [5] Elliott PM(1997)Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope Circulation 96 2509-678
  • [6] Fanciulli A(2015)The different clinical presentations of vasovagal syncope Heart 101 674-1080
  • [7] Fedorowski A(2013)Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity J Am Coll Cardiol 62 1075-173
  • [8] Furlan R(2011)Syncope due to idiopathic paroxysmal atrioventricular block: longterm follow-up of a distinct form of atrioventricular block J Am Coll Cardiol 58 167-205
  • [9] Kenny RA(2015)Adenosine and clinical forms of neurally-mediated syncope J Am Coll Cardiol 66 204-424
  • [10] Martín A(2013)Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation? Prog Cardiovasc Dis 55 418-1535